13 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18951851 | Modular Hip Distractor | MILO, MICHAEL | 3786 | Non-Final OA | Nov 19, 2024 |
| 18417805 | COMPOUNDS HAVING SELECTIVE INACTIVATION ACTIVITY | MACH, ANDRE | 1615 | Non-Final OA | Jan 19, 2024 |
| 18579710 | G-TUBE BLOCKAGE BLASTER | CARRILLO, BIBI SHARIDAN | 1711 | Non-Final OA | Jan 16, 2024 |
| 18370111 | SENSOR FOR THE DETECTION OF HYDROXYL FREE RADICALS | QIAN, SHIZHI | 1795 | Final Rejection | Sep 19, 2023 |
| 18238687 | Ferroptosis-HDAC Inhibitor Hybrid Anticancer Agents | SEITZ, ANTHONY JOSEPH | 1629 | Non-Final OA | Aug 28, 2023 |
| 18274549 | C PRIME AGENTS FOR TREATING METABOLIC DISORDERS | BRAUN, MADELINE E | 1624 | Non-Final OA | Jul 27, 2023 |
| 18353183 | Synergistic Inhibition of eIF5A and Notch Signaling | STEIN, LEAH ELIZABETH | 1641 | Non-Final OA | Jul 17, 2023 |
| 18216487 | URINARY CATHETER | MARCETICH, ADAM M | 3781 | Final Rejection | Jun 29, 2023 |
| 18093057 | ANTIMICROBIAL FILTRATION | HORGER, KIM S. | 1784 | Non-Final OA | Jan 04, 2023 |
| 17790288 | STRATIFYING RISK OF MALIGNANCY IN INDETERMINATE THYROID NODULES AND IMMUNO-GENOMIC MARKERS FOR EARLY DETECTION OF THYROID CANCER | MACFARLANE, STACEY NEE | 1675 | Final Rejection | Jun 30, 2022 |
| 17775932 | Methods and Kits using Internal Standards to Control for Complexity of Next Generation Sequencing(NGS) Libraries | VANN-OJUEKAIYE, KENDRA RAYCHELL | 1682 | Final Rejection | May 11, 2022 |
| 17737325 | Emulsion Formation Assisted by Corona Discharge and Electrohydrodynamic Pumping | BRAZIN, JACQUELINE | 1798 | Final Rejection | May 05, 2022 |
| 17178455 | SUPER SENSITIVE SENSOR FOR THE DETECTION OF HYDROXYL FREE RADICALS WITH SCAVENGING PROPERTIES | SUN, CAITLYN MINGYUN | 1795 | Final Rejection | Feb 18, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial